Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,240,100
+$1,733,430 QoQ
Shares Held
2,175,547
-7.8% QoQ
Ownership
1.96%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $4,148,480,732 across 73 Drug Manufacturers - Specialty & Generic names. AMLX ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,145,735 | $1,672,167,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
409,288 | $242,699,592 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,426,253 | $223,678,734 | |
| 4 | VTRS |
Viatris Inc
|
16,089,939 | $217,375,067 | |
| 5 | HLN |
Haleon plc
|
19,166,253 | $191,854,187 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
8,889,088 | $184,537,462 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
1,219,196 | $160,616,870 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
6,417,527 | $153,571,413 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,240,100 | 2,175,547 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,506,670 | 2,359,824 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $26,504,587 | 1,950,301 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,120,981 | 486,893 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,679,436 | 474,418 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,754,749 | 464,220 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,549,575 | 478,265 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,756,468 | 924,459 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,880,649 | 2,070,653 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $41,661,173 | 2,830,243 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $17,433,296 | 952,119 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $22,688,314 | 1,051,846 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,480,725 | 902,547 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,901,127 | 484,469 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,574,317 | 269,070 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $830,219 | 43,106 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $544,133 | 42,345 | Shares | Defined | 2022-10-27 | |
| No filing history on record for this holder in this stock. | ||||||